Research & Literature

Defining the syndromes of parathyroid failure after total thyroidectomy.

Lorente-Poch L, Sancho JJ, Muñoz-Nova JL, et al.

Gland surgery 2015; (4(1)):82-90 doi:10.3978/j.issn.2227-684X.2014.12.04.

Parathyroid hormone: anabolic and catabolic actions on the skeleton.

Silva BC, Bilezikian JP

Current opinion in pharmacology 2015; (22()):41-50.

The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Cianferotti L, Cricelli C, Kanis JA, et al.

Endocrine 2015; (50(1)):12-26 doi:10.1007/s12020-015-0606-x.

Stridor and apnea as the initial presentation of primary hypoparathyroidism.

Chou CT, Siegel B, Mehta D

International journal of pediatric otorhinolaryngology 2016; (80()):30-2.

New Method for the Approximation of Corrected Calcium Concentrations in Chronic Kidney Disease Patients.

Kaku Y, Ookawara S, Miyazawa H, et al.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2016; (20(1)):46-52 doi:10.1111/1744-9987.12351.

Management of Hypoparathyroidism: Present and Future.

Bilezikian JP, Brandi ML, Cusano NE, et al.

The Journal of clinical endocrinology and metabolism 2016; (101(6)):2313-24 doi:10.1210/jc.2015-3910.

Epidemiology and Diagnosis of Hypoparathyroidism.

Clarke BL, Brown EM, Collins MT, et al.

The Journal of clinical endocrinology and metabolism 2016; (101(6)):2284-99 doi:10.1210/jc.2015-3908.

22q11.2 deletion syndrome.

McDonald-McGinn DM, Sullivan KE, Marino B, et al.

Nature reviews. Disease primers 2015; (1()):15071 doi:10.1038/nrdp.2015.71.

Bone imaging in hypoparathyroidism.

Silva BC, Rubin MR, Cusano NE, Bilezikian JP

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2017; (28(2)):463-471 doi:10.1007/s00198-016-3750-0.

Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2.

Roszko KL, Bi RD, Mannstadt M

Frontiers in physiology 2016; (7()):458 doi:10.3389/fphys.2016.00458.

Serum 1,25-Dihydroxyvitamin D as a Biomarker of the Absence of Hypercalciuria in Postsurgical Hypoparathyroidism.

García-Pascual L, Barahona MJ, Perea V, Simó R

The Journal of clinical endocrinology and metabolism 2017; (102(1)):259-266 doi:10.1210/jc.2016-2987.

Diseases associated with calcium-sensing receptor.

Vahe C, Benomar K, Espiard S, et al.

Orphanet journal of rare diseases 2017; (12(1)):19 doi:10.1186/s13023-017-0570-z.

Heterotrimeric G proteins in the control of parathyroid hormone actions.

Bastepe M, Turan S, He Q

Journal of molecular endocrinology 2017; (58(4)):R203-R224 doi:10.1530/JME-16-0221.

Calcium and Bone Metabolism Indices.

Song L

Advances in clinical chemistry 2017; (82()):1-46 doi:10.1016/bs.acc.2017.06.005.

Parathyroid hormone: Data mining for age-related reference intervals in adults.

Farrell CL, Nguyen L, Carter AC

Clinical endocrinology 2018; (88(2)):311-317 doi:10.1111/cen.13486.

Physiology of the Calcium-Parathyroid Hormone-Vitamin D Axis.

Goltzman D, Mannstadt M, Marcocci C

Frontiers of hormone research 2018; (50()):1-13 doi:10.1159/000486060.

Current treatment of hypoparathyroidism: Theory versus reality waiting guidelines for children and adolescents.

Di Maio S, Soliman AT, De Sanctis V, Kattamis CC

Acta bio-medica : Atenei Parmensis 2018; (89(1)):122-131 doi:10.23750/abm.v89i1.7118.

American Thyroid Association Statement on Postoperative Hypoparathyroidism: Diagnosis, Prevention, and Management in Adults.

Orloff LA, Wiseman SM, Bernet VJ, et al.

Thyroid : official journal of the American Thyroid Association 2018; (28(7)):830-841 doi:10.1089/thy.2017.0309.

Hypoparathyroidism: is it that easy to treat?

Triantafyllou E, Yavropoulou MP, Anastasilakis AD, Makras P

Hormones (Athens, Greece) 2019; (18(1)):55-63 doi:10.1007/s42000-018-0032-6.

Increased mortality and morbidity in patients with chronic hypoparathyroidism: A population-based study.

Vadiveloo T, Donnan PT, Leese CJ, et al.

Clinical endocrinology 2019; (90(2)):285-292 doi:10.1111/cen.13895.

Surgical Hypoparathyroidism.

Kazaure HS, Sosa JA

Endocrinology and metabolism clinics of North America 2018; (47(4)):783-796 doi:10.1016/j.ecl.2018.07.005.

Hypoparathyroidism and the Kidney.

Peacock M

Endocrinology and metabolism clinics of North America 2018; (47(4)):839-853 doi:10.1016/j.ecl.2018.07.009.

Conventional Treatment of Hypoparathyroidism.

Babey M, Brandi ML, Shoback D

Endocrinology and metabolism clinics of North America 2018; (47(4)):889-900 doi:10.1016/j.ecl.2018.07.012.

Hypocalcemic disorders.

Bove-Fenderson E, Mannstadt M

Best practice & research. Clinical endocrinology & metabolism 2018; (32(5)):639-656 doi:10.1016/j.beem.2018.05.006.

Treatment of hypoparathyroidism.

Tecilazich F, Formenti AM, Frara S, et al.

Best practice & research. Clinical endocrinology & metabolism 2018; (32(6)):955-964 doi:10.1016/j.beem.2018.12.002.

Auditing the Efficacy and Safety of Alfacalcidol and Calcium Therapy in Idiopathic Hypoparathyroidism.

Saha S, Goswami R

The Journal of clinical endocrinology and metabolism 2019; (104(4)):1325-1335 doi:10.1210/jc.2018-02228.

Is calcium supplementation always needed in patients with hypoparathyroidism?

Al-Sharefi A, Glenister E, Morris M, Quinton R

Clinical endocrinology 2019; (90(6)):775-780 doi:10.1111/cen.13955.

Update on hypoparathyroidism.

Cusano NE, Bilezikian JP

Current opinion in rheumatology 2019; (31(4)):381-387 doi:10.1097/BOR.0000000000000618.

Molecular and clinical insights from studies of calcium-sensing receptor mutations.

Gorvin CM

Journal of molecular endocrinology 2019; (63(2)):R1-R16.

Unique classification of parathyroid dysfunction in patients with transfusion dependent thalassemia major using Nomogram-A cross sectional study.

Majid H, Jafri L, Ahmed S, et al.

Annals of medicine and surgery (2012) 2019; (45()):22-26 doi:10.1016/j.amsu.2019.07.016.

Assessing the Patient Experience of Hypoparathyroidism Symptoms: Development of the Hypoparathyroidism Patient Experience Scale-Symptom (HPES-Symptom).

Brod M, Waldman LT, Smith A, Karpf D

The patient 2020; (13(2)):151-162 doi:10.1007/s40271-019-00388-5.

Defining the Characteristics of Chronic Hypoparathyroidism Not Adequately Controlled on Conventional Therapy: Consensus Findings of Three European Delphi Panels.

Iqbal K, Dass N, Gip C, et al.

Advances in therapy 2019; (36(11)):3007-3016 doi:10.1007/s12325-019-01102-5.

Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13-country patient and caregiver survey.

Siggelkow H, Clarke BL, Germak J, et al.

Clinical endocrinology 2020; (92(2)):159-168 doi:10.1111/cen.14128.

Hypocalcaemic cardiomyopathy: a description of two cases and a literature review.

Válek M, Roblová L, Raška I, et al.

ESC heart failure 2020; (7(3)):1291-1301 doi:10.1002/ehf2.12693.

Hypoparathyroidism.

Bilezikian JP

The Journal of clinical endocrinology and metabolism 2020; (105(6)) doi:10.1210/clinem/dgaa113.

Diagnosis and management of hypocalcemia.

Pepe J, Colangelo L, Biamonte F, et al.

Endocrine 2020; (69(3)):485-495 doi:10.1007/s12020-020-02324-2.

Basal ganglia calcification in hypoparathyroidism and pseudohypoparathyroidism: local and systemic metabolic mechanisms.

Zavatta G, Clarke BL

Journal of endocrinological investigation 2021; (44(2)):245-253 doi:10.1007/s40618-020-01355-w.

Hypoparathyroidism in a Case of Transfusion Dependent Thalassemia.

Majumder A, Basu S

Journal of the ASEAN Federation of Endocrine Societies 2020; (35(1)):129-132 doi:10.15605/jafes.035.01.23.

Challenges in the management of chronic hypoparathyroidism.

Zavatta G, Clarke BL

Endocrine connections 2020; (9(10)):R229-R240.

Renal complications in patients with chronic hypoparathyroidism on conventional therapy: a systematic literature review : Renal disease in chronic hypoparathyroidism.

Gosmanova EO, Houillier P, Rejnmark L, et al.

Reviews in endocrine & metabolic disorders 2021; (22(2)):297-316 doi:10.1007/s11154-020-09613-1.

Alfacalcidol vs Calcitriol in the Management of Patient With Hypoparathyroidism: A Randomized Controlled Trial.

Saha S, Sreenivas V, Goswami R

The Journal of clinical endocrinology and metabolism 2021; (106(7)):2092-2102 doi:10.1210/clinem/dgab114.

Canadian national hypoparathyroidism registry: an overview of hypoparathyroidism in Canada.

Khan AA, AbuAlrob H, Punthakee Z, et al.

Endocrine 2021; (72(2)):553-561 doi:10.1007/s12020-021-02629-w.

Risk of Chronic Kidney Disease and Estimated Glomerular Filtration Rate Decline in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study.

Gosmanova EO, Chen K, Rejnmark L, et al.

Advances in therapy 2021; (38(4)):1876-1888 doi:10.1007/s12325-021-01658-1.

Risk of Nephrolithiasis and Nephrocalcinosis in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study.

Ketteler M, Chen K, Gosmanova EO, et al.

Advances in therapy 2021; (38(4)):1946-1957 doi:10.1007/s12325-021-01649-2.

Parathyroid hormone.

Leung EKY

Advances in clinical chemistry 2021; (101()):41-93 doi:10.1016/bs.acc.2020.06.005.

Determinants of hypercalciuria and renal calcifications in chronic hypoparathyroidism: A cross-sectional study.

Ridder LO, Harsløf T, Sikjaer T, et al.

Clinical endocrinology 2021; (95(2)):286-294 doi:10.1111/cen.14470.

Basal Ganglia Calcification Is Associated With Local and Systemic Metabolic Mechanisms in Adult Hypoparathyroidism.

Zavatta G, Tebben PJ, McCollough CH, et al.

The Journal of clinical endocrinology and metabolism 2021; (106(7)):1900-1917 doi:10.1210/clinem/dgab162.

Bone quality in hypoparathyroidism.

Tay YD, Tabacco G, Bilezikian JP

Minerva endocrinology 2021; (46(3)):325-334 doi:10.23736/S2724-6507.21.03527-2.

Fracture risk in hypoparathyroidism: a systematic review and meta-analysis.

Pal R, Bhadada SK, Mukherjee S, et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2021; (32(11)):2145-2153 doi:10.1007/s00198-021-05966-8.

Misclassification of calcium status in end-stage kidney disease using albumin-adjusted calcium levels.

Law MM, Smith JD, Schneider HG, Wilson S

Nephrology (Carlton, Vic.) 2021; (26(9)):725-732 doi:10.1111/nep.13910.

Hypoparathyroidism and Fahr's syndrome: case series.

Arruda ACG, Guerra ACDZ, Pessoa CH, et al.

Jornal brasileiro de nefrologia 2022; (44(4)):592-596 doi:10.1590/2175-8239-JBN-2020-0243.

[Review of clinical practice guidelines for hypoparathyroidism].

Kovaleva EV, Eremkina AK, Krupinova JA, et al.

Problemy endokrinologii 2021; (67(4)):68-83 doi:10.14341/probl12800.

Poor performance of albumin or protein-adjusted plasma calcium to diagnose dyscalcemia in hospitalized patients: A confirmatory study in a general internal medicine department.

Alhenc-Gelas M, Lefevre G, Bachmeyer C, et al.

La Revue de medecine interne 2022; (43(4)):206-211 doi:10.1016/j.revmed.2021.11.006.

Hypocalcemia-Induced QT Interval Prolongation.

Tang JKK, Rabkin SW

Cardiology 2022; (147(2)):191-195 doi:10.1159/000515985.

The Russian Registry of Chronic Hypoparathyroidism.

Kovaleva EV, Eremkina AK, Elfimova AR, et al.

Frontiers in endocrinology 2022; (13()):800119 doi:10.3389/fendo.2022.800119.

Vertebral fractures, trabecular bone score and their determinants in chronic hypoparathyroidism.

Saha S, Mannar V, Kandasamy D, et al.

Journal of endocrinological investigation 2022; (45(9)):1777-1786 doi:10.1007/s40618-022-01818-2.

UK national chronic hypoparathyroidism audit.

Kiam JS, Sharma V, Glenister L, et al.

Clinical endocrinology 2022; (97(5)):562-567 doi:10.1111/cen.14798.

Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop.

Khan AA, Bilezikian JP, Brandi ML, et al.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(12)):2568-2585 doi:10.1002/jbmr.4691.

Initial Assessment and Monitoring of Patients with Chronic Hypoparathyroidism: A Systematic Current Practice Survey.

Van Uum S, Shrayyef M, M'Hiri I, et al.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(12)):2630-2641 doi:10.1002/jbmr.4698.

Management of Hypoparathyroidism.

Khan AA, Guyatt G, Ali DS, et al.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(12)):2663-2677 doi:10.1002/jbmr.4716.

Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.

Khan AA, Rubin MR, Schwarz P, et al.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2023; (38(1)):14-25 doi:10.1002/jbmr.4726.

Hypoparathyroidism: Genetics and Diagnosis.

Mannstadt M, Cianferotti L, Gafni RI, et al.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(12)):2615-2629 doi:10.1002/jbmr.4667.

Complications, Symptoms, Presurgical Predictors in Patients With Chronic Hypoparathyroidism: A Systematic Review.

Yao L, Hui X, Li M, et al.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(12)):2642-2653 doi:10.1002/jbmr.4673.

Hypoparathyroidism: update of guidelines from the 2022 International Task Force.

Clarke BL

Archives of endocrinology and metabolism 2022; (66(5)):604-610.

Vitamin D in hypoparathyroidism: insight into pathophysiology and perspectives in clinical practice.

Cipriani C, Cianferotti L

Endocrine 2023; (81(2)):216-222 doi:10.1007/s12020-023-03354-2.

Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism.

Watts NB, Bilezikian JP, Bone HG, et al.

Journal of the Endocrine Society 2023; (7(5)):bvad043 doi:10.1210/jendso/bvad043.

Use of rhPTH(1-84) for hypoparathyroidism during early pregnancy and lactation.

Liao EP, Cusano NE

Endocrinology, diabetes & metabolism case reports 2023; (2023(2)).

Renal complications in chronic hypoparathyroidism - a systematic cross-sectional assessment.

Gronemeyer K, Fuss CT, Hermes F, et al.

Frontiers in endocrinology 2023; (14()):1244647 doi:10.3389/fendo.2023.1244647.

Significance of QTc Interval in Chronic Hypoparathyroidism and its Correlates.

Namjoshi P, Saha S, Sharma V, et al.

The Journal of clinical endocrinology and metabolism 2025; (110(4)):e1062-e1067 doi:10.1210/clinem/dgae346.

Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial.

Clarke BL, Khan AA, Rubin MR, et al.

The Journal of clinical endocrinology and metabolism 2025; (110(4)):951-960 doi:10.1210/clinem/dgae693.

Cognitive Function in Individuals with Chronic Hypoparathyroidism-A Prospective Observational Study.

Tmava-Berisha A, Fahrleitner-Pammer A, Stross T, et al.

The Journal of clinical endocrinology and metabolism 2025; (110(8)):2157-2163 doi:10.1210/clinem/dgae800.

An activating calcium-sensing receptor variant with biased signaling reveals a critical residue for Gα11 coupling.

Benson MR, Wyatt RA, Levine MA, Gorvin CM

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2025; (40(2)):270-282 doi:10.1093/jbmr/zjae199.

[Albumin adjustment of total serum calcium - is it worth doing?]

Mamedova EO, Golounina OO, Belaya ZE

Problemy endokrinologii 2024; (70(6)):45-61 doi:10.14341/probl13503.

Hypoparathyroidism: diagnosis, management and emerging therapies.

Khan S, Khan AA

Nature reviews. Endocrinology 2025; (21(6)):360-374 doi:10.1038/s41574-024-01075-8.

Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR).

Khan AA, AbuAlrob H, Ali DS, et al.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2025; (36(4)):673-684 doi:10.1007/s00198-025-07410-7.

Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes.

Roumpou A, Palermo A, Tournis S, et al.

Endocrine reviews 2025; (46(4)):576-620 doi:10.1210/endrev/bnaf010.

Best practice recommendations for the diagnosis and management of hypoparathyroidism.

Khan AA, Ali DS, Bilezikian JP, et al.

Metabolism: clinical and experimental 2025; (171()):156335 doi:10.1016/j.metabol.2025.156335.

Chronic Hypoparathyroidism-Current and Emerging Therapies.

Khan S, Khan AA

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2025; (31(11)):1478-1487 doi:10.1016/j.eprac.2025.07.011.

Switch From rhPTH1-84 to TransCon PTH With Individual Dose Adjustment in Adult Hypoparathyroidism-4-Week Results.

Siggelkow H, Peschke KA, Tsourdi E, et al.

Journal of the Endocrine Society 2025; (9(9)):bvaf113 doi:10.1210/jendso/bvaf113.

rhPTH(1-84) for hypoparathyroidism: a randomized study of patient-reported outcomes.

Brandi ML, Vokes T, Appelman-Dijkstra NM, et al.

European journal of endocrinology 2025; (193(2)):310-319 doi:10.1093/ejendo/lvaf148.

Consensus-Based Recommendations for the Diagnosis, Treatment, and Monitoring of Hypoparathyroidism: Insights from the DACH Region.

Tsourdi E, Amrein K, Meier C, et al.

Calcified tissue international 2025; (116(1)):107 doi:10.1007/s00223-025-01414-5.

Early U.S. Real-World Treatment Patterns and Outcomes in Palopegteriparatide Treatment for Patients With Hypoparathyroidism.

Graham T, Shoback DM, Abbott L, et al.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2025; (31(12)):1568-1575 doi:10.1016/j.eprac.2025.08.008.

Revised European Society of Endocrinology Clinical Practice Guideline: Treatment of Chronic Hypoparathyroidism in Adults.

Bollerslev J, Buch O, Cardoso LM, et al.

European journal of endocrinology 2025; (193(5)):G49-G78 doi:10.1093/ejendo/lvaf222.

Hydrochlorothiazide with salt restriction in nonsurgical hypoparathyroidism: a placebo-controlled single-blinded randomized crossover trial assessing efficacy and safety.

Jha V, Mukherjee S, Bhadada SK, et al.

JBMR plus 2025; (9(12)):ziaf174 doi:10.1093/jbmrpl/ziaf174.

Management of hypoparathyroidism during pregnancy following late maternal diagnosis of DiGeorge syndrome: a case report.

Shah MK, Kishore P, Shah M, Friedman N

Journal of medical case reports 2026; (20(1)):73 doi:10.1186/s13256-025-05650-z.

Advancing hypoparathyroidism treatment: FDA approval of Palopegteriparatide as a promising orphan drug.

Shahid SR, Shahid K, Ehsan S, et al.

Annals of medicine and surgery (2012) 2026; (88(2)):1209-1212 doi:10.1097/MS9.0000000000004734.

Severe pediatric hypocalcemia in Vietnam: etiologic profile, clinical outcomes and risk factors in 246 cases.

Nguyen TT, Dang GTK, Bui PT, et al.

Frontiers in endocrinology 2026; (17()):1701713 doi:10.3389/fendo.2026.1701713.

Morning urinary calcium/creatinine ratio as a sex-specific screening tool for detecting hypercalciuria in hypoparathyroidism.

Berr CM, Fuss CT, Gronemeyer K, et al.

European journal of internal medicine 2026; (148()):106740 doi:10.1016/j.ejim.2026.106740.

Successful transition from rhPTH(1-84) to palopegteriparatide in chronic hypoparathyroidism.

Chiardi I, Trimboli P

JCEM case reports 2026; (4(4)):luag048 doi:10.1210/jcemcr/luag048.

Refractory hypocalcaemia-induced laryngeal spasm requiring emergency intubation in a malnourished young woman: overcoming diagnostic and therapeutic barriers in resource-limited settings.

Negash AA, Woudineh MT, Mohammed YE, et al.

International journal of emergency medicine 2026; (19(1)).

Proton pump inhibitor induced hypocalcemia presenting with carpopedal spasm- a rare case report from Nepal.

Pahari N, Pahari M, Ghimire S, et al.

International journal of emergency medicine 2026; (19(1)).

Sustained improvement in renal function with palopegteriparatide in adults with chronic hypoparathyroidism: 2-year results from the phase 3 PaTHway-trial.

Rejnmark L, Gosmanova EO, Khan AA, et al.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2026; (41(9)):922-933 doi:10.1093/jbmr/zjag085.

Clinical Characteristics, Treatment Patterns, and Complications in Permanent Hypoparathyroidism: A Large Retrospective Cross-Sectional Study.

Soyer AK, Polat ŞB, İnönü G, et al.

Calcified tissue international 2026; (117(1)).

Pharmacodynamics of sustained levels of PTH following palopegteriparatide treatment in adults with hypoparathyroidism.

Khan AA, Rejnmark L, Jain R, et al.

Journal of the Endocrine Society 2026; (10(7)):bvag098 doi:10.1210/jendso/bvag098.

Limited diagnostic utility of albumin-corrected calcium in the intensive care unit: A prospective comparison with ionised calcium.

Özdemir E, Yılmaz T, Düzenci D

PloS one 2026; (21(7)):e0354233 doi:10.1371/journal.pone.0354233.

Delayed recognition of hypomagnesemia causing refractory Hypocalcemia after Reoperative neck surgery in a resource-limited setting. a case report.

Flores CS, Vásquez SM, Pineda A, et al.

Oxford medical case reports 2026; (2026(7)):omag132 doi:10.1093/omcr/omag132.

Hypocalcaemic cardiomyopathy with recurrent heart failure: a natural rechallenge case report with 30-month follow-up.

Pang N, Hu RM, Xu L, et al.

European heart journal. Case reports 2026; (10(8)):ytag571 doi:10.1093/ehjcr/ytag571.